Related Experiment Video

Updated: Sep 28, 2026

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
08:40

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

Dendritic cells as adjuvants in antitumor immune therapy

T Felzmann1, H Gadner, W Holter

  • 1Forschungsinstitut für krebskranke Kinder, Wien, Austria. felzmann@ccri.univie.ac.at

Onkologie
|November 5, 2002
PubMed

Insights

Traditional tumor vaccines face challenges with antigen delivery and adjuvant efficacy. Dendritic cells (DCs) show promise as effective adjuvants, enhancing antitumor immunity in preclinical models and cancer patients.

Area of Science:

  • Immunology
  • Oncology
  • Vaccine Development

Background:

  • Traditional tumor vaccines struggle with effective antigen delivery and poorly understood adjuvants.
  • Conventional adjuvants often fail to activate both humoral and cellular immunity against tumors.

Purpose of the Study:

  • To describe recent advances in understanding dendritic cell (DC) function.
  • To review the clinical applications of DCs as adjuvants in antitumor immunotherapy.

Main Methods:

  • In vitro pulsing of dendritic cells (DCs) with tumor antigens.
  • In vivo application of antigen-pulsed DCs in experimental mouse tumor systems.
  • Evaluation of DC-based immunotherapy in cancer patients.

Main Results:

  • Antigen-pulsed DCs induced tumor rejection in mouse models.
  • DC-based preparations enhanced antitumor immunity in cancer patients.
  • Demonstrated the potential of DCs as effective vaccine adjuvants.

Conclusions:

  • Dendritic cells represent a promising approach to overcome limitations in current tumor vaccine strategies.
  • Understanding DC function is crucial for advancing DC-based antitumor immunotherapies.
  • Clinical applications of DCs show potential for improving cancer treatment outcomes.

More Related Videos

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation07:04

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation

Published on: September 16, 2018

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Antigen Presenting Cells01:22

Antigen Presenting Cells

The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...